Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: The Dietary Guidelines 3 Diets Study [NA]
A completed clinical trial studying three dietary patterns in individuals with Type 2 diabetes mellitus (Dietary Guidelines 3 Diets Study) i…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2) [NA]
An update on the ongoing EMINENT-2 trial evaluating the safety, feasibility, and efficacy of the ReCET Procedure in Type 2 diabetes; the stu…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study
ENDOCare-SCREEN is a screening study for metabolic liver dysfunction and related metabolic conditions, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate the efficacy and safety of CMG190303 in patients with Type 2 diabetes mellitus and dyslip…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Does Screening of Coronary Artery Disease an Efficient Public Health Strategy in Patients With Type 2 DIABetes
Clinical trial update on whether screening for coronary artery disease is an efficient public health strategy in patients with type 2 diabet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS [NA]
This clinical trial update describes study NCT02087826, which investigates the acute glycemic response to metformin using a mixed meal toler…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells [NA]
A clinical trial is evaluating the safety and feasibility of endoscopic duodenal injections of autologous mesenchymal stem cells in adults w…
-
FDA approval · 2026-01-14FDA Approved: SITAGLIPTIN PHOSPHATE — Original Application (Sandoz Inc)
FDA approved an original application for sitagliptin phosphate from Sandoz Inc, establishing the generic availability of sitagliptin phospha…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial) [Phase 3]
The document announces the completion of REMODEL, a Phase 3 trial comparing semaglutide with placebo in adults with type 2 diabetes and chro…
-
FDA approval · 2026-01-14FDA Approved: LIRAGLUTIDE — Original Application (Orbicular Pharmaceutical Technologies Private Limited)
FDA approves the original application for a generic liraglutide product from Orbicular Pharmaceutical Technologies Private Limited.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Effects of Marching Exercise With Cognitive Training on Physical, Cognitive Function, and Autonomic Cardiovascular Responses in Older Adults With Type 2 Diabetes Mellitus [NA]
A completed clinical trial evaluating marching exercise combined with cognitive training on physical and cognitive function and autonomic ca…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Trial to Learn How Safe AZD9550 Monotherapy and Combined With AZD6234 is in People With or Without Type 2 Diabetes Who Are Living With Obesity and Overweight [Phase 1, Phase 2]
This clinical trial update from AstraZeneca describes a Phase 1/2 study evaluating AZD9550 alone and in combination with AZD6234 in adults w…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas
This clinical trial update notes a completed study comparing SGLT2 inhibitors versus sulfonylureas in people with type 2 diabetes and COPD t…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Targeted Assessment in High-Risk paTients With dIAbetes to ideNtify Undiagnosed Heart Failure [NA]
Clinical trial update on a targeted assessment approach to identify undiagnosed heart failure in high-risk patients with diabetes; the study…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Investigating Metabolic and Psychological Adaptations in a Clinical Trial [NA]
This clinical trial update notes an ongoing study addressing metabolic and psychological adaptations in obesity and type 2 diabetes; the tri…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose [NA]
An ongoing University of New Mexico clinical trial is investigating whether the perceived effort during resistance exercise influences blood…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) [Phase 1]
A Phase 1 trial of MK-1403 in participants with type 2 diabetes mellitus is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period [NA]
A clinical trial update indicating that recruitment is ongoing (enrolling by invitation) for adults with Type 1 or Type 2 diabetes to evalua…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. [Phase 2]
A Phase 2 trial comparing once-daily AZD5004 to placebo over 26 weeks in adults with type 2 diabetes assessed efficacy, safety, and tolerabi…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Comparative Effects of Aspirin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver Disease [NA]
A completed study compared the effects of aspirin versus SGLT2 inhibitors on liver enzymes, lipid profile, and FibroScan findings in individ…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing HR17031 with insulin glargine in adults with Type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Study of the Performance of the GLUCUBE System in Patients With Type 2 Diabetes [NA]
This clinical trial update describes the performance of the GLUCUBE System in adults with Type 2 diabetes and notes that the study status is…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Effect of Tvns in Obesity [NA]
A Cairo University-sponsored clinical trial is evaluating the effect of Tvns in obesity, including participants with Type 2 diabetes mellitu…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: AI-Driven MRF Type 2 Diabetes Integrating DHT IF and Resistance Training to OM and Functional Outcomes [NA]
An active but not currently recruiting clinical trial evaluating an AI-driven metabolic rehabilitation framework for Type 2 Diabetes Mellitu…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use [NA]
A study is evaluating continuous versus periodic use of continuous glucose monitoring in people with type 2 diabetes who are not treated wit…